Assessment of dietary intake of molybdenum in relation to tolerable upper intake level. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food and Environment by Strand, Tor et al.
 VKM Report 2018: 05 
Assessment of dietary intake of 
molybdenum in relation to tolerable 
upper intake level 
Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of 
the Norwegian Scientific Committee for Food and Environment 
  
VKM Report 2018: 05 
Report from the Norwegian Scientific Committee for Food and Environment (VKM) 2018: 05 
Assessment of dietary intake of molybdenum in relation to tolerable upper intake level 
Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the 
Norwegian Scientific Committee for Food and Environment 
14.03.2018 
ISBN: 978-82-8259-302-1 
ISSN 2535-4019 
Norwegian Scientific Committee for Food and Environment (VKM) 
Po 4404 Nydalen 
N – 0403 Oslo 
Norway 
Phone: +47 21 62 28 00 
Email: vkm@vkm.no 
vkm.no 
vkm.no/english 
Cover photo: iStock photo 
Suggested citation: VKM (2018). Assessment of dietary intake of molybdenum in relation 
to tolerable upper intake. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food 
and Allergy of the Norwegian Scientific Committee for Food and Environment. VKM Report 
2018: 05, ISBN: 978-82-8259-302-1, Oslo, Norway. Available online: vkm.no 
 
  
VKM Report 2018: 05 
Assessment of dietary intake of molybdenum in relation to 
tolerable upper intake.  
Author preparing the draft statement  
Tor A. Strand 
Assessed and approved 
The opinion has been assessed by the Panel on Nutrition, Dietetic Products, Novel Food and 
Allergy of the Norwegian Scientific Committee for Food and Environment 
(Vitenskapskomiteen for mat og miljø, VKM). Kristin Holvik (chair), Livar Frøyland, 
Margaretha Haugen, Sigrun Henjum, Martinus Løvik, Tonje Holte Stea, Tor A. Strand and 
Christine Louise Parr (external expert). 
(Panel members in alphabetical order after chair of the panel) 
Acknowledgment  
The Panel on Nutrition, Dietetic Products, Novel Food and Allergy has answered the request 
from the Norwegian Food Safety Authority. Project leader from the VKM secretariat has been 
Bente Mangschou. Tor A Strand is acknowledged for his valuable work on this opinion. 
Competence of VKM experts 
Persons working for VKM, either as appointed members of the Committee or as external 
experts, do this by virtue of their scientific expertise, not as representatives for their 
employers or third party interests. The Civil Services Act instructions on legal competence 
apply for all work prepared by VKM. 
  
  
VKM Report 2018: 05 
Table of Contents 
Summary .................................................................................................................. 5 
Sammendrag på norsk ............................................................................................. 7 
Abbreviations and/or glossary ................................................................................. 8 
EFSA - Dietary Reference Values (DRVs) (EFSA, 2010) .............................................. 9 
IOM - Dietary Reference Intakes (DRIs) (IOM, 2000) ............................................... 10 
NNR -Recommended Intake (NNR Project Group, 2012) ........................................... 11 
Expert group on vitamins and minerals (EVM), UK (EVM, 2003) ................................ 12 
Background as provided by the Norwegian Food Safety Authority ....................... 13 
Assessment of molybdenum ............................................................................................ 13 
Terms of reference as provided by the Norwegian Food Safety Authority ............ 15 
Assessment molybdenum ....................................................................................... 16 
1 Introduction ................................................................................................... 16 
2 Recommendations and tolerable upper intake levels.................................... 17 
2.1 Recommendations ................................................................................................. 17 
2.2 Tolerable upper intake levels .................................................................................. 17 
Scientific Committee on Food (SCF, 2000), EU ......................................................... 18 
Institute of Medicine (IOM, 2001), USA ................................................................... 18 
Expert Group on Vitamins and Minerals (EVM, 2003), UK .......................................... 19 
Nordic Nutrition Recommendations (NNR, 2012) ...................................................... 19 
 Summary tolerable upper intake levels ......................................................... 20 
3 Intakes and scenarios for molybdenum ........................................................ 21 
3.1 Scenario calculations for molybdenum ..................................................................... 22 
4 Assessment of the intakes of molybdenum ................................................... 23 
4.1 Evaluation of molybdenum intakes, including scenarios with supplementation ........... 23 
5 Uncertainties .................................................................................................. 24 
6 Answers to the terms of reference ................................................................ 25 
7 Data gaps ....................................................................................................... 26 
8 References ..................................................................................................... 27 
 
  
VKM Report 2018: 05  5 
Summary 
The Norwegian Scientific Committee for Food and Environment (Vitenskapskomiteen for mat 
og miljø, VKM) has, at the request of the Norwegian Food Safety Authority (Mattilsynet; 
NFSA), evaluated the intake of molybdenum. VKM has also conducted scenario calculations 
to illustrate the consequences of amending maximum limits for molybdenum to 100, 250, 
500 or 1000 µg/day in food supplements. The previous maximum limit was 250 µg/day. 
Molybdenum is as a cofactor for some important enzymes in humans. These enzymes are 
involved in the catabolism of sulfur amino acids and heterocyclic compounds, including 
purines and pyridines. A distinct molybdenum deficiency has not been described in animals 
when subjected to molybdenum restriction, despite considerable reduction in the activity of 
molybdoenzymes. Molybdenum deficiency is not observed in healthy humans. The estimated 
Adequate Intake (AI) proposed by the European Food Safety Authority (EFSA) is 65 µg per 
day for men and women. Legumes, grains, and nuts are major contributors of molybdenum 
in the diet.  
Molybdenum is a potential antagonist to copper absorption, but symptoms of copper 
deficiencies due to excess molybdenum intake have only been observed in ruminants. Based 
on the effect on reproduction and growth in animals, tolerable upper intake levels (ULs) have 
been estimated to be 2 mg/day by the U.S. Institute of Medicine (IOM) in 2001 and 
0.6 mg/day by the Scientific Committee on Food (SCF) in 2000. These ULs were based on 
the same scientific evidence, but IOM used an uncertainty factor (UF) of 30 and SCF used a 
UF of 100 because the evidence base was considered to be weak. 
Because of the limited safety data on molybdenum, VKM support the use of the default 
uncertainty factors at 100 for extrapolation of data from animal studies to humans. 
Additionally, molybdenum deficiency is very rare and no studies have indicated a nutritional 
need for additional molybdenum from dietary supplements. The ULs for children were 
derived by adjusting the adult UL according to default body weights.   
According to the scenario estimations, only the highest suggested maximum limit of 1000 µg 
molybdenum from food supplements will lead to exceedance of the UL for adults. For 1-3 
year old children, all the suggested maximum limits for molybdenum will lead to exceedance 
of the UL. In children 4-10 years, supplements with 250, 500 or 1000 µg molybdenum will 
lead to exceedance of the ULs, whereas for adolescents 11-17 years, the UL will be 
exceeded with supplemental doses at 500 or 1000 µg per day. 
VKM emphasises that the current assessment of maximum limits for molybdenum in food 
supplements is merely based on published reports concerning upper levels from the SCF 
(2000, EU), IOM (2001, USA), EVM (2003, UK) and NNR (2012, Nordic countries). VKM has 
not conducted any systematic review of the literature for the current opinion, as this was 
outside the scope of the terms of reference from NFSA. 
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Sammendrag på norsk 
Vitenskapskomiteen for mat og miljø (VKM) har vurdert inntaket av molybden i befolkningen 
på oppdrag fra Mattilsynet.  
VKM har også gjort scenarioberegninger for å illustrere konsekvensene av å fastsette 
maksimumsgrensene for molybden i kosttilskudd til 100, 250, 500 eller 1000 µg/dag. Den 
tidligere maksimumsgrensen for molybden var 250 µg per døgndose. 
Molybden er en kofaktor for noen viktige enzymer i mennesker. Disse enzymene er involvert 
i katabolismen av svovelaminosyrer og heterocykliske forbindelser, inkludert puriner og 
pyridiner. Til tross for betydelig reduksjon i enzymaktiviteten er det ikke rapportert om 
manifestert molybdenmangel i dyr som er utsatt for molybdenrestriksjoner. Molybdenmangel 
er ikke vist hos friske mennesker. Adekvat inntak (AI) er beregnet til 65 μg per dag for menn 
og kvinner. Belgfrukter, korn og nøtter er viktige kilder til molybden i maten.  
Molybden kan påvirke absorbsjon av kobber, men symptomer på kobbermangel på grunn av 
høyt inntak av molybden er kun observert i drøvtyggere. Øvre tolerabelt inntaksnivå (UL) har 
blitt estimert til å være mellom 2 og 0,6 mg per dag, og er basert på effekten på 
reproduksjon og vekst hos dyr. Nivåene er fastsatt av henholdsvis U.S. Institute of Medicine 
(IOM) i 2001 og Scientific Committee on Food (SCF) i 2000. Den samme vitenskapelige 
evidensen ligger til grunn for begge disse øvre tolerable inntaksnivåene, men IOM brukte en 
usikkerhetsfaktor på 30, mens SCF brukte en usikkerhetsfaktor på 100 fordi 
evidensgrunnlaget ble vurdert som svakt. 
På grunn av usikkerheten i de vitenskapelige studiene som er lagt til grunn for det øvre 
tolerable inntaksnivået samt inntaksdataene og den lave risikoen for molybdenmangel, 
støtter VKM SCFs bruk av en høyere usikkerhetsfaktor og et øvre tolerabelt inntaksnivå på 
0,6 mg/dag for voksne. Øvre tolerable inntaksnivåer for barn er fastsatt ved å justere denne 
verdien i forhold til standard kroppsvekter hos de ulike aldersgruppene. 
I henhold til scenarioberegningene vil kun den høyeste maksimumsgrensen for molybden i 
kosttilskudd på 1000 µg per dag føre til en overskridelse av øvre tolerable inntaksnivå hos 
voksne. For barn 1-3 år vil alle de foreslåtte maksimumsgrensene medføre overskridelse av 
øvre tolerabelt inntaksnivå. For barn 4-10 år vil tilskudd med 250, 500 eller 1000 µg 
molybden medføre overskridelse av øvre tolerabelt inntaksnivå, mens for ungdom 11-17 år, 
vil øvre tolerable inntaksnivå overskrides ved doser på 500 eller 1000 µg molybden per dag. 
VKM presiserer at denne vurderingen av maksimumsgrenser for molybden i kosttilskudd er 
basert på publiserte rapporter om øvre inntaksnivåer fra SCF (2000, EU), IOM (2001, USA), 
EVM (2003, Storbritannia) og NNR (2012, de nordiske landene) og EFSA. Ettersom mandatet 
i bestillingen fra Mattilsynet var å vurdere øvre inntaksnivå basert på allerede eksisterende 
rapporter, har VKM ikke gjennomført et eget systematisk litteratursøk for å vurdere det 
samlede kunnskapsgrunnlaget i denne vurderingen.  
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Abbreviations and/or glossary 
Abbreviations 
AI – adequate intake 
AR  – average requirement 
bw  – body weight 
CI  – confidence interval  
DRI  – dietary reference intake 
DRV  – dietary reference value 
DTU  – Technical University of Denmark 
EAR  – estimated average requirement (IOM).  
EFSA  – European Food Safety Authority 
EVM  – Expert group on vitamins and minerals of the Food Standard Agency, UK 
IOM  – Institute of Medicine, USA 
IU  – international unit 
LOAEL  – lowest observed adverse effect level 
NFSA  – Norwegian Food Safety Authority [Norw.: Mattilsynet] 
NNR  – Nordic Nutrition Recommendations 
NOAEL  – no observed adverse effect level 
PRI  – population reference intakes 
RDA  – recommended dietary allowances 
RI  – recommended intake 
SCF  – Scientific Committee on Food 
SUL  – safe upper intake level 
UF  – uncertainty factor 
UL  – tolerable upper intake level 
VKM  – Norwegian Scientific Committee for Food and Environment [Norw.: 
Vitenskapskomiteen for mat og miljø] 
Glossary 
P5, P25, P50, P75 or P95-exposure is the calculated exposure at the 5, 25, 50, 75 or 95-
percentile. 
Percentile is a term for visualising the low, medium and high occurrences of a 
measurement by splitting the whole distribution into one hundred equal parts. A percentile is 
a statistical measure indicating the value below which a given percentage of the observations 
fall. E.g. the 95-percentile is the value (or score) below which 95 percent of the observations 
are found. 
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EFSA - Dietary Reference Values (DRVs) (EFSA, 2010) 
Average Requirement (AR) is the level of intake of a defined group of individuals 
estimated to satisfy the physiological requirement of metabolic demand, as defined by a the 
specific criterion for adequacy for the nutrient, in half of the heathy individuals in a life stage 
or sex group, on the assumption that the supply of other nutrients and energy is adequate.   
If an AR cannot be determined than an Adequate Intake is used.   
Adequate Intake (AI) is defined as the average (median) daily level of intake based on 
observed, or experimentally determined approximations or estimates of a nutrient intake, by 
a group (or groups) of apparently healthy people, and therefore assumed to be adequate. 
The practical implication of an AI is similar to that of a population reference intake, i.e. to 
describe the level of intake that is considered adequate for health reasons. The 
terminological distinction relates to the different ways in which these values are derived and 
to the resultant difference in the "firmness" of the value.  
Population Reference Intake (PRI) is derived from AR of a defined group of individuals 
in an attempt to take into account the variation of requirements between individuals.  
 
 
Figure 1: Population reference intake (PRI and average requirements (AR), if the requirement has a 
normal distribution and the inter-individual variation is known (EFSA, 2010). 
Lower Threshold Intake (LTI) is the lowest estimate of requirement from the normal 
distribution curve, and is generally calculated on the basis of the AR minus twice its SD. This 
will meet the requirement of only 2.5% of the individuals in the population.  
Tolerable Upper intake Level (UL) is the maximum level of total chronic daily intake of a 
nutrient (from all sources) judged to be unlikely to pose a risk of adverse health effects to 
humans.  
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Figure 2: Relationship between individual intake and risk of adverse effects due to insufficient or 
excessive intake. 
IOM - Dietary Reference Intakes (DRIs) (IOM, 2000) 
Estimated Average Requirement (EAR) is a nutrient intake value that is estimated to 
meet the requirement of half the healthy individuals in a life stage and gender group.  
Recommended Dietary Allowances (RDA) is the dietary intake level that is sufficient to 
meet the nutrient requirement of nearly all (97 to 98 percent) healthy individuals in a 
particular life stage and gender group. RDA = EAR + 2 SDEAR or if insufficient data to 
calculate SD a factor of 1.2 is used to calculate RDA; RDA = 1.2*EAR 
Adequate Intake (AI) is the recommended intake value based on observed or 
experimentally determined approximations or estimates of nutrient intake by a group (or 
groups) of healthy people that are assumed to be adequate – used when an RDA cannot be 
determined 
Tolerable Upper Intake Level (UL) is the highest level of nutrient intake that is likely to 
pose no risk of adverse health effects for almost all individuals in the general population.  
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Figure 3: Dietary reference intakes. 
NNR -Recommended Intake (NNR Project Group, 2012) 
Average Requirement (AR) is defined as the lowest long-term intake level of a nutrient 
that will maintain a defined level of nutritional status in an individual i.e. the level of a 
nutrient that is sufficient to cover the requirement for half of a defined group of individuals 
provided that there is a normal distribution of the requirement.  
ARNNR = EARIOM = AREFSA 
Recommended Intake (RI) is defined as the amount of a nutrient that meets the known 
requirement and maintains good nutritional status among practically all healthy individuals in 
a particular life stage or gender group. RI= AR + 2SDAR.  
RINNR = RDAIOM = PRIEFSA 
Upper Intake Level (UL) is defined as the maximum level of long-term (months or years) 
daily nutrient intake that is unlikely to pose a risk of adverse health effects in humans.  
ULNNR =ULIOM = ULEFSA 
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Figure 4: Derivation of Upper Intake Level (UL)  
UF: Uncertainty factor 
Expert group on vitamins and minerals (EVM), UK (EVM, 2003) 
Safe Upper Intake Level (SUL): EVM used SUL instead of UL and defined SUL as the 
determination of doses of vitamins and minerals that potentially susceptible individuals could 
take daily on a life-long basis, without medical supervision in reasonable safety. The setting 
of these levels provided a framework within which the consumer could make an informed 
decision about intake, having confidence that harm should not ensue. The levels so set will 
therefore tend to be conservative. 
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Background as provided by the 
Norwegian Food Safety Authority 
Directive 2002/46/EC on food supplements was implemented into Norwegian law in 2004 in 
Regulation 20 May 2004 No. 755 on food supplements. Pursuant to Directive 2002/46/EC, 
common maximum and minimum levels of vitamins and minerals in food supplements shall 
be set in the EU. The European Commission started to establish common limits in 2006, but 
the work was temporarily put on standstill in 2009. The time frame for the further work is 
not known.  
National maximum limits for vitamins and minerals were established in the former vitamin 
and mineral supplements regulation from 1986 and were continued in the 2004 regulation. 
The national maximum and minimum limits in the food supplement regulation were 
established a long time before the food supplement directive was adopted, and the limits 
were consequently not established in accordance with the criteria for limits set in the food 
supplement directive. Maximum limits for vitamins and minerals which were not already 
revised according to the criteria in article 5 in the food supplement directive, were therefore 
repealed from 30 May 2017.  
Maximum limits for levels of vitamins and minerals in food supplements shall be set on basis 
of the following criteria, pursuant to article 5 in Directive 2002/46/EC:  
• Upper safe levels of vitamins and minerals established by scientific risk assessment 
based on generally accepted scientific data, taking into account, as appropriate, the 
varying degrees of sensitivity of different consumer groups  
• Intake of vitamins and minerals from other dietary sources 
When the maximum levels are set, due account should also be taken of reference intakes of 
vitamins and minerals for the population. 
Pending establishment of common maximums limits in the EU, the Norwegian Food Safety 
Authority is evaluating the national maximum limits for vitamins and minerals in food 
supplements. 
Norwegian authorities will as soon as possible, when it exists a scientific basis, and pending 
establishment of common maximums limits in the EU, establish new national maximum limits 
for those vitamins and minerals where limits were repealed 30 May 2017.  
Assessment of molybdenum  
The Norwegian Food Safety Authority will consider establishing a new national maximum 
limit for molybdenum in the food supplement regulation.  
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The former maximum limit for molybdenum was 250 µg per daily dose, but this was 
repealed from 30 May 2017. The minimum limit and permitted molybdenum substances that 
may be used in the manufacture of food supplements, are listed in annex 1 and annex 2 in 
the food supplement regulation.   
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Terms of reference as provided by the 
Norwegian Food Safety Authority 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) requests the Norwegian Scientific 
Committee for Food and Environment (VKM) to assess the intake of molybdenum from the 
diet, in all age groups in the population above 1 year.  
As there is no data on molybdenum in the Norwegian food composition data base (KBS), 
VKM is requested to evaluate if other relevant intake data can be used - included Danish 
intake data estimated by the Technical University of Denmark (DTU) and the EFSA Scientific 
Opinion on Dietary Reference Values for molybdenum (2013).  
VKM is also requested to evaluate the consequences of establishing a maximum limit for 
molybdenum in food supplements of 100, 250, 500 or 1000 μg per daily dose, and to 
evaluate these scenarios against existing tolerable upper intake levels.  
  
  
VKM Report 2018: 05  16 
Assessment molybdenum 
1 Introduction 
Molybdenum is an essential mineral commonly found in legumes, including beans, peas and 
lentils, leafy vegetables, grains, nuts and liver. The molybdenum content of plant foods 
varies according to the soil content in which the plants are grown. Legumes, grains, and nuts 
are major contributors of molybdenum in the diet (Pennington and Jones, 1987; Tsongas et 
al., 1980). Mineral water or "hard" tap water may also contain molybdenum. 
Molybdenum is a cofactor for some important enzymes. These include sulfite oxidase, which 
is necessary for metabolism of sulfur-containing amino acids; xanthine oxidase, which 
contributes to antioxidant capacity of the blood; aldehyde oxidase, which joins with xanthine 
oxidase in the metabolism of drugs and toxins; and mitochondrial amidoxime-reducing 
component, which accelerates the removal of certain toxic substances. 
Molybdenum is efficiently absorbed over a large range of intakes, which suggests that 
molybdenum absorption is a passive process. However, the mechanism of molybdenum 
absorption (transcellular or paracellular transport) and the location(s) within the 
gastrointestinal tract responsible for absorption have not been well studied (Nielsen, 1999 
cited in IOM, 2001). Molybdenum concentrations in whole blood vary widely, with an 
average at about 5 nmol/L (Verseick et al., 1978). Protein-bound molybdenum constitutes 
between 83 and 97 percent of the total molybdenum in erythrocytes. Molybdenum retention 
may be affected in part through formation of the molybdopterin complex. Urinary excretion 
is a direct reflection of the dietary molybdenum intake level (Turnlund et al., 1995a; 
Turnlund et al., 1995b). Stable isotope studies showing molybdenum retention at low 
molybdenum intakes and rapid excretion at high intakes suggest that the kidney is the 
primary site of molybdenum homeostatic regulation.  
Clinical signs of molybdenum deficiency in otherwise healthy humans have not been 
observed. Symptoms suggestive of molybdenum deficiency have been observed in ruminants 
when subjected to molybdenum restriction, despite considerable reduction in the activity of 
molybdoenzymes.  
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2 Recommendations and tolerable 
upper intake levels 
2.1 Recommendations 
There are no Norwegian recommendations for intake of molybdenum. The Nordic Nutrition 
Recommendations (2012) concluded that no recommendations could be given for 
molybdenum due to lack of sufficient evidence (NNR Project Group, 2012). 
The European Food Safety Authority (EFSA) adopted Dietary Reference Values (DRVs) for 
molybdenum (EFSA, 2013). EFSA concluded that data is insufficient for deriving Average 
Requirements (ARs) or Population Reference Intakes (PRIs). Adequate Intakes (AIs) at 
65 µg/day was proposed for adults, including pregnant and lactating women. Observed 
molybdenum intakes from mixed diets in Europe were taken into consideration in setting this 
value. The AIs by age categories are presented in Table 2.1-1. 
 Table 2.1-1 Adequate Intakes for molybdenum from EFSA (2013).  
Age, both sexes µg/day 
1-3 years 15 
4-6 years 20 
7-10 30 
11-14 years 45 
15-17 years 65 
≥18 years* 65 
*Including pregnancy and lactation. 
2.2 Tolerable upper intake levels 
In general, molybdenum compounds are considered to have low toxicity in humans. There 
are limited toxicity data on molybdenum in humans and most of the toxicity data are for 
animals, especially ruminants. Ruminants are more sensitive to molybdenum than 
monogastric animals, and the basis for the toxicity of molybdenum in ruminants may not be 
relevant for humans. Molybdenum toxicity in animals varies highly according to species, age, 
sex, and duration of exposure (Vyskocil and Viau, 1999). In monogastric laboratory animals, 
molybdenum has been associated with reduced growth or weight loss, renal failure, skeletal 
abnormalities, infertility, anemia, diarrhea, and thyroid injury (Vyskocil and Viau, 1999). 
None of the above-mentioned effects in animals have been observed in humans, and it is 
accordingly impossible to determine which ones might be considered relevant in humans.  
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Scientific Committee on Food (SCF, 2000), EU 
In 2000, The Scientific Committee on Food (SCF) established an UL using a 9-week rat 
study, which was pivotal because of its design, the number of animals, demonstration of a 
clear dose-response relationship and clear toxicological endpoints (Fungwe et al., 1990). The 
no observed adverse effect level (NOAEL) in this study was found to be 0.9 mg/kg bw/day 
for reproductive toxicity. SCF used an uncertainty factor (UF) of 100 because the evidence 
base was considered to be weak. This comprised a factor of 10 for protecting human sub-
populations sensitive to copper deficiencies due to high molybdenum intake (as a result of 
molybdenum-copper antagonism), and another factor of 10 due to the lack of knowledge 
about reproductive effects of molybdenum in humans and incomplete data on the 
toxicokinetics in man. This provided an UL of approximately 0.01 mg/kg bw/day, equivalent 
to 0.6 mg/person/day for adults, which also covered pregnant and lactating women. The UL 
for children was derived by extrapolating from the adult UL on a body weight basis using the 
reference body weights for Europe published by the SCF (SCF, 1993). 
Table 2.2-2 Tolerable upper intake levels for molybdenum in different age groups suggested by 
the SCF (2000).  
Age (years) UL mg/day  
1-3 0.1 
4-6 0.2 
7-10 0.25 
11-14 0.4 
15-17 0.5 
Adults* 0.6 
*Including lactation and pregnancy. 
Institute of Medicine (IOM, 2001), USA 
The U.S. Institute of Medicine (IOM) established an UL in 2001 which also was based mainly 
on data from animal studies. 
The study by Fungwe et al. (1990) provided a dose-response relationship for adverse 
reproductive effects in female rats. The NOAEL from this study was 0.9 mg/kg/day and the 
lowest observed adverse effect level (LOAEL) was 1.6 mg/kg/day of molybdenum. This study 
was supported by observations of reproductive effects in mice in a three-generation study at 
a single dose of 1.5 mg/kg/day (Schroeder and Mitchener, 1971). Since only one dose level 
was used in this study, it was difficult to use this study independently to determine a LOAEL. 
In addition, Jeter and Davis (1954) noted decreased fertility in male rats after 13 weeks of 
exposure to 8 mg/kg/day of molybdenum. The NOAEL from that study was 2 mg/kg/day. 
IOM stated that these observations suggested that numerous adverse reproductive effects 
were encountered in rats and mice at dietary molybdenum levels exceeding the NOAEL of 
0.9 mg/kg/day established from the study of Fungwe et al. (1990). 
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IOM argued that there was not sufficient data to justify lowering the degree of uncertainty 
from the usual UF for extrapolating from experimental animals to humans. Thus, the usual 
value of 10 was selected. An UF of 3 for intra-species variation was based on the expected 
similarity in pharmokinetics of molybdenum among humans. Although Vyskocil and Viau 
(1999) had argued for a larger UF for intraspecies differences, they had based their concerns 
on possible interactions with copper and concerns about copper-deficient humans. IOM 
stated that recent information suggested that molybdenum does not have any effect on 
copper metabolism in humans (Turnlund and Keyes, 2000 cited in IOM, 2001), and used an 
UF of 30. 
The NOAEL of 0.9 mg/kg/day was divided by the overall UF of 30 to obtain an UL of 
30 μg/kg/day for humans. The value of 30 μg/kg/day was multiplied by the average of the 
reference body weights for adult women, 61 kg. The resulting UL for adults was rounded to 
2 mg/day (2000 μg/day). 
Although adult men and women have different reference body weights, the uncertainties in 
the estimation of the UL were considerable and distinction of separate ULs for men and 
women was therefore not attempted. A common UL for both genders at 2 mg/day was also 
supported by limited human data from Deosthale and Gopalan (1974) who demonstrated no 
effect on uric acid or copper excretion in humans exposed to 1.5 mg/day for an adult. The 
adult UL of 2 mg/day was adjusted for children and adolescents on the basis of relative body 
weights. 
Table 2.2-1 Tolerable upper intake levels for molybdenum in different age groups suggested by 
the IOM (2001).  
Age (years) UL mg/day  
1-3 0.3 
4-8 0.6 
9-13 1.1 
14-18* 1.7 
19 and older* 2 
*Including lactation and pregnancy 
Expert Group on Vitamins and Minerals (EVM, 2003), UK 
The UK Expert Group on Vitamins and Minerals (EVM) concluded: “There are insufficient data 
from human (Kovalsky et al., 1961) or animal studies (Fairhall et al., 1945; Arrington & 
Davies, 1953; Schroeder & Mitchener, 1971) to establish a safe upper level for 
molybdenum”, and refrained from adopting or defining any upper level for molybdenum. 
Nordic Nutrition Recommendations (NNR, 2012) 
The Nordic Nutrition recommendations (NNR Project Group, 2012) did not conclude on any 
ULs and merely cited the conclusions from the reports above.  
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 Summary tolerable upper intake levels 
Conclusions concerning ULs from previous reports for molybdenum from the SCF and IOM 
are shown in Table 2.2.1-1. The ULs are based on the same animal studies, but the SCF 
have argued for an UF at 100, whereas the IOM have used a lower UF at 30, and have 
consequently concluded on a higher UL than the SCF.  
Table 2.2.1-1 Overview of ULs in adults set by various authorities.  
  
 UL 
µg/day 
Based on NOAEL LOAEL UF 
IOM, 2001 2000 Rat studies 0.9 mg/kg/day 1.6 
mg/kg/day 
30 
SCF, 2000 600 Rat studies 0.9 mg/kg/day 1.6 
mg/kg/day 
100 
EVM, 2003 - - - - - 
NNR, 2012 - - - - - 
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3 Intakes and scenarios for 
molybdenum 
There are no data on habitual intake of molybdenum in the Norwegian population, because 
no available data exists for molybdenum in the Norwegian food composition table. We have 
therefore used data from Denmark.  
Through communication with the Danish Veterinary and Food Administration, NFSA has 
obtained data on median and 95th percentile dietary molybdenum intakes in Denmark 
calculated by the Technical University of Denmark (DTU).  
The Danish molybdenum data are obtained from the nationally representative survey of diet 
and physical activity in the Danish population aged 4-75 years, carried out in 2011-2013 
(DANSDA) (DTU, 2015). Diet was assessed through a 4-day food record. According to the 
DTU, the intake estimates for molybdenum are considered to be of high uncertainty, and the 
estimates of the intake of molybdenum should be interpreted with caution.  
EFSA published intake data of molybdenum from several European counties in the DRV-
report from 2013 (EFSA, 2013). The mean intakes in adults were mainly reported to be in 
the range between 75 and 157 µg/day. 
Table 3-1 Estimated median and 95-percentile of dietary intake of molybdenum from food 
(µg/day) in age and gender groups in Denmark. 
Age group Median 
intakes 
from food 
P95 from 
food 
1-3 years 30 45 
4-6 years 41 68 
7-10 years 46 85 
11-14 years 40 69 
15-17 years 41  78 
25-34 years 
(women) 
49 79 
55-75 years 
(women) 
54 93 
65-75 years 
(women) 
52 93 
25-34 years 
(men) 
59 103 
65-75 years 
(men) 
61 103 
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3.1 Scenario calculations for molybdenum 
For scenario calculations VKM used the intake group at P95 from food alone estimated from 
intake data in the Danish population to calculate molybdenum intake and added the 
suggested supplementation levels from NFSA (100, 250, 500 or 1000 µg molybdenum per 
day).  
Table 3.1-1 Calculated total molybdenum intakes for various age groups in scenarios with 100, 250, 
500 or 1000 µg as supplements added to the P95 of intake from food alone (µg/day).  
  
Age group P95 from 
food 
Including  
100 µg from 
suppl 
Including 
250 µg from 
suppl 
Including 
500 µg from 
suppl 
Including 
1000 µg 
from suppl 
1-3 years 45 145 295 545 1045 
4-6 years 68 168 318 568 1068 
7-10 years 85 185 335 585 1085 
11-14 years 69 169 319 569 1069 
15-17 years 78 178 328 578 1078 
25-34 years 
(women) 
79 179 329 579 1079 
55-75 years 
(women) 
93 193 343 593 1093 
65-75 years 
(women) 
93 193 343 593 1093 
25-34 years 
(men) 
103 203 353 603 1103 
65-75 years 
(men) 
103 203 353 603 1103 
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4 Assessment of the intakes of 
molybdenum 
For assessment of the intakes of molybdenum, VKM has used the UL from SCF of 600 µg per 
day for adults and bodyweight adjusted values for children and adolescents. This is the 
lowest of the two available ULs. VKM decided to apply the lower of the two because of the 
limited toxicity data on molybdenum in humans. Most of the toxicity data used to set the 
existing ULs are extrapolated from animal studies. This justifies use of the default 
uncertainty factor of 100 for extrapolation of data from animal studies to humans (10 for 
inter-species variability x 10 for intra-human variability). Furthermore, molybdenum 
deficiency is generally not observed in humans and there are no studies indicating a need for 
additional molybdenum from dietary supplements.  
The Danish molybdenum intake data are considered to be the best available as no data are 
available for the Norwegian population. The mean intakes of molybdenum varies throughout 
Europe, and there is no scientific basis for assessing whether the Danish intake is 
representative of Norwegian conditions. 
The Danish intakes of molybdenum in the 95th percentile from food alone are well below the 
ULs in all age groups. The median intakes in some adult age groups may be below the 
Adequate Intakes described in chapter 2. However, the Danish molybdenum estimates are 
considered to be of high uncertainty, and no molybdenum deficiency have been reported in 
human studies.  
4.1 Evaluation of molybdenum intakes, including scenarios with 
supplementation  
According to the scenario estimations in adults, the dietary molybdenum intake at the 95th 
percentile and additionally 100, 250 or 500 µg molybdenum from food supplements will be 
approximately at or below the UL while 1000 µg molybdenum from food supplements will 
lead to exceedance of the UL for adults. It should be noted that adding 500 µg of 
molybdenum slightly exceeded the UL for adult males. This is not considered to be of health 
concern because the lower of the two available ULs were used. 
For 1-3 year old children, all the suggested maximum limits for molybdenum will lead to 
exceedance of the UL. In children 4-10 years, supplements with 250, 500 or 1000 µg 
molybdenum will lead to exceedance of the ULs, whereas for adolescents 11-17 years, the 
UL will be exceeded with supplemental doses at 500 or 1000 µg per day.  
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5 Uncertainties 
For the determinations of the ULs for molybdenum, SCF and IOM arrived at different 
conclusions. EVM and NNR did not conclude, emphasising the uncertainty regarding 
establishment of these ULs for adults as well as for children and adolescents.  
There are no long-term clinical studies investigating potential benefits and harms from 
molybdenum intake in humans. As molybdenum toxicity in animals is highly variable, 
extrapolation from animal studies to humans are considered to be uncertain. 
There were no data for molybdenum intake from Norway. We have therefore used data from 
Denmark which may not reflect the situation in Norway well. The Danish data are considered 
to be of high uncertainty. 
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6 Answers to the terms of reference 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) has requested the Norwegian 
Scientific Committee for Food and Environment (VKM) to assess the intake of molybdenum 
from the diet, in all age groups in the population above 1 year.  
VKM was also requested to evaluate the consequences of establishing a maximum limit for 
molybdenum in food supplements of 100, 250, 500 or 1000 µg per daily dose, and to 
evaluate these scenarios against existing tolerable upper intake levels.  
In the assessment of molybdenum, VKM uses the tolerable upper intake level established by 
the SCF at 600 µg/day for adults. According to the scenario estimations in adults, the dietary 
molybdenum intake at the 95th percentile and additionally 100, 250 or 500 µg molybdenum 
from food supplements will be approximately at or below the UL. Because we are using the 
lower of the two ULs and because molybdenum compounds in general are considered to 
have low toxicity in humans, we accept an estimated intake from the 95th percentile at or 
slightly above the UL. Intake of 1000 µg molybdenum from food supplements will lead to 
exceedance of the UL for adults.  
For 1-3 year old children, all the suggested maximum limits for molybdenum will lead to 
exceedance of the UL. In children 4-10 years, supplements with 250, 500 or 1000 µg 
molybdenum will lead to exceedance of the ULs, whereas for adolescents 11-17 years, the 
UL will be exceeded with supplemental doses at 500 or 1000 µg per day.  
VKM emphasises that the current assessment of maximum limits for molybdenum in food 
supplements is merely based on published reports concerning upper levels from the SCF 
(2000, EU), IOM (2001, USA), EVM (2003, UK) and NNR (2012, Nordic countries). VKM has 
not conducted any systematic review of the literature for the current opinion, as this was 
outside the scope of the terms of reference from NFSA. 
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7 Data gaps 
There are little data from human and animal studies on the toxicity of molybdenum from the 
diet or from supplements. There are also no data on the intake of molybdenum in the 
Norwegian population.  
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